PowderJect Pharmaceuticals was a British vaccine, drug and diagnostics delivery company founded by Brian Bellhouse. They developed a needle-free injection system for delivering medications and vaccines.
In 1993, PowderJect was spun out of the University of Oxford with the help of Isis Innovation.
In 2003, the company was taken over by the American Chiron Corporation for £542 million. The company's CEO was Paul Drayson, Baron Drayson, son-in-law of the founder, Brian Bellhouse, and they received £100 million following the takeover. Drayson received £43m for his 8% holding, Bellhouse £19.5m for his 3.6% stake, and their family trusts received £41m.
References
- Elliott, Francis (14 April 2002). "Labour donor is no stranger to controversy". Telegraph. Retrieved 29 June 2017.
- Andrew Clark (19 January 2002). "Interview: Paul Drayson, Powderject Pharmaceuticals | Business". The Guardian. Retrieved 29 June 2017.
- ^ Fletcher, Richard (27 April 2003). "PowderJect to be sold for £500m". Daily Telegraph. UK. Retrieved 27 June 2017.
- ^ Geoffrey Gibbs (20 May 2003). "£43m windfall for PowderJect chief | Business". The Guardian. Retrieved 27 June 2017.